The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 20, 2021
Seqirus, a global leader in influenza prevention, and a business of CSL Limited (ASX: CSL), announced that the FDA approved FLUCELVAX® QUADRIVALENT (...
read more
Wednesday, October 20, 2021
Merck and Eisai announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted positive ...
read more
Wednesday, October 20, 2021
Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of VAXNEUVANCE...
read more
Wednesday, October 20, 2021
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...
read more
Wednesday, October 20, 2021
Boehringer Ingelheim announced the FDA approved the supplemental Biologics License Application (sBLA) for Cyltezo® (adalimumab-adbm) as the first ...
read more
Wednesday, October 20, 2021
Ionis Pharmaceuticals, Inc. partner Biogen announced topline results from its placebo-controlled pivotal Phase 3 VALOR study of tofersen (BIIB067), an...
read more
Thursday, October 14, 2021
Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, ...
read more
Thursday, October 14, 2021
Merck announced that the FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy, with or without bevacizumab, for the ...
read more
Thursday, October 14, 2021
Otsuka and H. Lundbeck report that the FDA has accepted a Supplemental New Drug Application (sNDA) for the treatment of schizophrenia in adolescents ...
read more
Thursday, October 14, 2021
Regeneron Pharmaceuticals announced that the FDA has accepted for priority review a Biologics License Application (BLA) for REGEN-COV® (casirivimab ...
read more
Wednesday, October 13, 2021
The FDA has approved Eli Lilly and Company's Verzenio® (abemaciclib), in combination with endocrine therapy (tamoxifen or an aromatase inhibitor), for...
read more
Wednesday, October 13, 2021
Takeda announced that the FDA Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously to recommend use of maribavir (TAK-620) for the ...
read more
Wednesday, October 13, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the FDA ...
read more
Wednesday, October 13, 2021
Merck announced the submission of an Emergency Use Authorization (EUA) application to the FDA for molnupiravir, an investigational oral antiviral ...
read more
Wednesday, October 13, 2021
Genentech announced that gantenerumab, an anti-amyloid beta antibody developed for subcutaneous administration, has been granted Breakthrough Therapy ...
read more